期刊文献+

胸水IL-18在结核性和恶性胸腔积液中的水平与意义 被引量:4

Level of interlukin 18 and its significance in tuberculous pleural effusion and malignant pleural effusion
下载PDF
导出
摘要 目的探讨胸水IL-18在结核性和恶性胸腔积液的水平和意义。方法选取2004年1月 ̄2005年5月在哈尔滨医科大学附属第二医院呼吸内科住院的未经治疗的胸腔积液患者48例,其中结核性胸腔积液组24例,恶性胸腔积液组24例。用酶联免疫吸附法(ELISA)检测结核性和恶性胸腔积液中IL-18浓度。结果结核性胸腔积液组IL-18浓度(263.37±67.64)ng/L显著高于恶性胸腔积液组(92.15±26.66)ng/L(P<0.05)。以胸水IL-18150ng/L为临界值,对结核性胸腔积液组诊断敏感性83%、特异性91.7%、准确性87.5%。 [Objective] To evaluate the level of interlukin 18 and its significance in tuberculous pleural effusion and malignant pleural effusion. [Methods] We selected 48 patients of pleural effusion in the wards of Department of Respiratory Internal Medicine, the Second Affiliated Hospital of Harbin Medical University during January 2004 and May 2005. Forty-eight specimens of pleural effusions were collected from 48 patients with pleural effusion. Of them 24 pleural effusion were diagnosed as tuberculous, and 24 as malignant. The levels of IL-18 of pleural effusion in tubercular pleurisy and malignant pleural effusion sufferersly were detected by ELISA. [Results] The level of IL-18 in tuberculous effusion (263.37±67.64) ng/L was significant higher than that in malignant pleural effusion (92.15±26.66) ng/L (P 〈0.05). The cut-of values for the IL-18 was defined. It was 150 ng/L. The sensitivity and specificity of IL-18 for tuberculous pleural effusion were 83.0% and 91.7%. [Conclusion] IL-18 could be used as valuable parameters for the differentiation of tuberculous effusion from malignant.
作者 吴晓梅
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2006年第15期2356-2357,2360,共3页 China Journal of Modern Medicine
关键词 白细胞介素18 结核/恶性 胸腔积液 IL-18 tubercular/malignant pleural effusion
  • 相关文献

参考文献6

  • 1OKAMURA H,TSUTSI H,KOMATSU T,et al.Cloning of a new cytokine that induces IFN-gamma production by T cells[J].Nature,1995,378(6552):88-91.
  • 2USHIO S,NAMBA M,OKURA T,et al.Cloning of the cDNA For human IFN-Y -inducing factor,expression in Escherichi coli and studies on the biological activities of the protein[J].J Immunol,1996,156:4274-4279.
  • 3刘京衢.白细胞介素-18——一种新的致炎性细胞因子[J].国外医学(创伤与外科基本问题分册),2000,21(2):95-98. 被引量:3
  • 4陈吉泉,罗文侗,曹雪涛.IL-18及其抗肿瘤作用[J].国外医学(免疫学分册),2000,23(4):239-243. 被引量:7
  • 5SUGAWARA I.Interleukin-18and infectious diseases.With special emphasis on diseases induccd by intracellular pathogens[J].Microbes Infect,2000,2(10):1257-1263.
  • 6SONG C H,LEE J S,NAM H H,et al.IL-18 production in human pulmonary and pleural tuberculosis[J].Scand-J-Immunol,2002,56(6):611-618.

二级参考文献12

  • 1Kazuki Yamanaka,Isao Hara,Hiroshi Nagai,Hideaki Miyake,Kazuo Gohji,Mark J. Micallef,Masashi Kurimoto,Soichi Arakawa,Sadao Kamidono. Synergistic antitumor effects of interleukin-12 gene transfer and systemic administration of interleukin-18 in a mouse bladder cancer model[J] 1999,Cancer Immunology, Immunotherapy(6):297~302
  • 2M. J. Micallef,Kenshi Yoshida,Sachiko Kawai,Toshiharu Hanaya,Keizo Kohno,Shigeyuki Arai,Tadao Tanimoto,Kakuji Torigoe,Mitsukiyo Fujii,Masao Ikeda,Masashi Kurimoto. In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites[J] 1997,Cancer Immunology, Immunotherapy(6):361~367
  • 3Tone M,A. J.Thompson S, Tone Y et al[].J Immunol.1997
  • 4Tsutsui H,Matsui K,Kawada N et al. J Immunol . 1997
  • 5Dinarello CA,Novick D,Puren AJ et al. Journal of Leukocyte Biology . 1998
  • 6Bohn E,Sing A,Zumbihl R et al. J Immunol . 1998
  • 7Sareneva T,Matikainen S,Kurimoto M et al. J Immunol . 1998
  • 8Meyer ZBC,Cramer S,Trumpfheller C et al. Clinical and Experimental Immunology . 1997
  • 9Tsuji H,Mukaida N,Harada A et al. J Immunol . 1999
  • 10Sakao Y,Takeda K,Tsutsui H et al. International Immunology . 1999

共引文献7

同被引文献30

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部